Cardiovascular Disease in Women: the Yentl Syndrome Gender-related Issues in Medicine UCLA December 11, 2012 C. Noel Bairey Merz, M.D., F.A.C.C, F.A.H.A.

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
Ischaemic Heart Disease- Implications of Gender Dr Kaye Birks School of Rural Health Monash University Australia Gender Competency Training for Medical.
What Have We Learned from the CRUSADE Registry
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
1 Women & Heart Disease Julia C. Orri, Ph.D. Biol. 330 November 21, 2006.
Health Care Facilitator Program at Lawrence Berkeley Laboratory
CABG GUIDELINES SANJAY DRAVID, M.D.. INTRODUCTION ACC/AHA GUIDELINE UPDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (JACC 2004; 44: AND CIRCULATION.
“Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute Myocardial Infarction and Heart Failure Paul A Heidenreich,
Ischemic Heart Diseases IHD
Women and Heart Disease: Triage Criteria Symptoms versus Reality.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
Orlando, Florida – October 7, 2011 Cardiac Rehab: Improving Outcomes One Step at a Time Martha Gulati MD, MS, FACC, FAHA Associate Professor of Medicine.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation? July
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Myocardial Ischemia Redefined: Optimal Care in CAD.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
Management of Stable Angina SIGN 96
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
Reducing Risk of Heart Disease & Stroke - A Life Long Quest Jeffrey P. Gold, M.D. University of Toledo Medical Center.
STRIVE TM What Is the Evidence That Critical Pathways Work? UCLA Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) ACC Guidelines Applied.
European Society of Cardiology Cardiovascular diseases in women.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
S. HUNT Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
Morbidity and Mortality in Contemporary CAD Patients With Hypertension Treated With Either a Verapamil/Trandolapril or Beta-Blocker/Diuretic Strategy (INVEST):
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Aspirin Resistance: Significance, Detection and Clinical Management of This Real Phenomenon Webcast May 10 th, 2004 Sponsored by.
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
AA-2-1 Jerome D. Cohen, MD, FACC, FACP Professor of Internal Medicine / Cardiology Director, Preventive Cardiology Programs St. Louis University Health.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
6/04 CRUSADE: A National Quality Improvement Initiative C an R apid Risk Stratification of U nstable Angina Patients S uppress AD verse Outcomes with E.
ACC/AHA 2006 guidelines on the management of PAD.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
TACTICS- TIMI 18 Treat Angina with Aggrastat TM and Determine Cost of Therapy with an Invasive or Conservative Strategy.
Antiplatelet Interventions in Acute Coronary Syndromes.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
The Case for Sex and Gender Specific Medicine: Science, Policy and Health Disparities Research Council of Norway June 5, 2015 Oslo, Norway C. Noel Bairey.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Management Strategies for Post-Intervention in Patients with CAD VBWG.
Date of download: 7/7/2016 From: Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Presidential address: quality of cardiovascular.
Atherosclerotic Cardiovascular Heart Disease in Women
Women and Cardiovascular Disease
Management of Hypertension according to JNC 7
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Revascularization in Patients With Left Ventricular Dysfunction:
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Clinical need for determination of vulnerable plaques
Gender Disparity in Treatment of Coronary Artery Disease?
Cholesterol practice questions
European Heart Association Journal 2007 April
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Cardiovascular Epidemiology and Epidemiological Modelling
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

Cardiovascular Disease in Women: the Yentl Syndrome Gender-related Issues in Medicine UCLA December 11, 2012 C. Noel Bairey Merz, M.D., F.A.C.C, F.A.H.A Women’s Guild Endowed Chair in Women’s Health Barbra Streisand Women’s Heart Center Preventive and Rehabilitative Cardiac Center Cedars-Sinai Heart Institute Los Angeles, California USA

Bernadine P. Healy, M.D.

EDITORIAL The Yentl Syndrome Bernadine Healy, M.D. N ENGL J MED 1991; 325: Yentl, the 19th-century heroine of Isaac Bashevis Singer's short story, had to disguise herself as a man to attend school and study the Talmud. Being "just like a man" has historically been a price women have had to pay for equality. Being different from men has meant being second-class and less than equal for most of recorded time and throughout most of the world. It may therefore be sad, but not surprising, that women have all too often been treated less than equally in social relations, political endeavors, business, education, research, and health care.

Problem: Adverse Mortality Gap Resulting in a New Female CVD Majority (National Center for Health Statistics and American Heart Association) Current Strategies Not Working Optimally in Women

Disparities in CVD Treatment for Women 35,835 pts with NSTEMI: 41% women35,835 pts with NSTEMI: 41% women Women had:Women had:  DM, HTN, age;  CAD events  DM, HTN, age;  CAD events  Early ASA, heparin, GPIIb-IIIa, ACE-I  Early ASA, heparin, GPIIb-IIIa, ACE-I  Revascularizations: CABG  41%  Revascularizations: CABG  41%  Discharge ASA, beta blocker, ACE-I, statins (Four Magic Pills)*  Discharge ASA, beta blocker, ACE-I, statins (Four Magic Pills)*  Death, MI, CHF  Death, MI, CHF Blomkalns AL et al. CRUSADE NSTEMI database. J Am Coll Cardiol. 2005;45: * Associated with a 90% reduction in recurrent major adverse cardiac events

Sex and Gender Differences in CVD Terminology: Sex = biological sexual differentiation, (e.g. women have ovaries, men have testes) Gender = socio-cultural attributes of the biological sex, e.g. women have complex social networks, men have wives

Sex and Gender Differences in CVD More Terminology: Sex genotype = XX chromosomal makeup, e.g. XX dictates ovarian development of stromal cells in utero. Sex phenotype = genotype expression given the certain conditions, e.g. premenopausal women higher estrogen levels due to ovulation; postmenopausal women have lower estrogen levels due to no ovulation. Both are XX genotype but differ in phenotypic expression.

Sex and Gender Differences in CVD Sex differences in perception = women have greater perception (high frequency non-auditory brain testing). Gay men are intermediate between women (higher perception) and men (lower perception), suggesting that this may be genotypic 1 Sex differences in pain = women have lower thermal pain thresholds compared to men. Thresholds appear mediated by estrogen levels, with higher E2 levels associated with enhanced pain, suggesting that this may be phenotypic 2 1 Shaywitz et al, Nature 1995;373:607; 2 Fillingim et al, Pain Forum 1995;4:209

Sex and Gender Differences in CVD Gender differences in reporting = women are more comfortable discussing feelings with friends and reporting symptoms to physicians 1, possibly due to gender-related acculturation Gender differences in physician response to symptoms = physicians are more likely to evaluate men compared to women and minorities 2, possibly due to gender-related presentation styles, and/or cultural sexism/racism biases 1 Stoverink J Fam Pract 1996;43:567

Sex and Gender Difference in CVD Consequences of Sex and Gender Symptom Issues: If women perceive chest pain sooner after the onset of ischemia/MI, this will lead to “longer” estimated “ischemia onset” times in the ED, potentially leading to conclusions that “women delay seeking treatment ”1, as well as making more women “ineligible” for thrombolytic therapy. These may contribute to more adverse outcomes. 2 If women report generally more symptoms suggestive of chest pain, it will be a less effective diagnostic tool, e.g. less specific for epicardial disease 3. This may lead to physician lack of confidence in testing, and may also suggest that chest pain symptoms may be difficult to optimize as a diagnostic tool. 1 Meischke Ann Emerg Med 1993;22:1597; 2 Vaccarino, Ann Int Med 2001;134:173; 3 Diamond NEJM 1979;300:1350

Potential Explanations for Disparities in CVD Treatment in Women Blame the victim – women do not seek healthcare for symptoms and/or delay seeking attentionBlame the victim – women do not seek healthcare for symptoms and/or delay seeking attention Ageism – women are older on average and older patients are less aggressively treatedAgeism – women are older on average and older patients are less aggressively treated Sexism (medical judgment) – women are less likely to have and/or die from CADSexism (medical judgment) – women are less likely to have and/or die from CAD Biological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” diseaseBiological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” disease

Potential Explanations for Disparities in CVD Treatment in Women Blame the victim – women do not seek healthcare for symptoms and/or delay seeking attentionBlame the victim – women do not seek healthcare for symptoms and/or delay seeking attention Ageism – women are older on average and older patients are less aggressively treatedAgeism – women are older on average and older patients are less aggressively treated Sexism (medical judgment) – women are less likely to have and/or die from CADSexism (medical judgment) – women are less likely to have and/or die from CAD Biological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” diseaseBiological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” disease

Gender Differences in Healthcare Seeking in the ED for CV Symptoms: Women and men report CV symptoms with same frequency McKinlay JFl, J Health and Social Behavior 1996;37:1

Gender Differences in ED Care for CV Symptoms: Women receive less assessment for CV symptoms McKinlay JFl, J Health and Social Behavior 1996;37:1

Potential Explanations for Disparities in CVD Treatment in Women Blame the victim – women do not seek healthcare for symptoms and/or delay seeking attentionBlame the victim – women do not seek healthcare for symptoms and/or delay seeking attention Ageism – women are older on average and older patients are less aggressively treatedAgeism – women are older on average and older patients are less aggressively treated Sexism (medical judgment) – women are less likely to have and/or die from CADSexism (medical judgment) – women are less likely to have and/or die from CAD Biological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” diseaseBiological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” disease

Sex and Myocardial Infarction (MI) Mortality: Largest Gaps in Young Women Vaccarino V et al. NRMI. N Engl J Med. 1999;341: Hospital Mortality (%) OverallOverall < Age (years) WomenWomen MenMen MenWomen

Potential Explanations for Disparities in CVD Treatment in Women Blame the victim – women do not seek healthcare for symptoms and/or delay seeking attentionBlame the victim – women do not seek healthcare for symptoms and/or delay seeking attention Ageism – women are older on average and older patients are less aggressively treatedAgeism – women are older on average and older patients are less aggressively treated Sexism (medical judgment) – women are less likely to have and/or die from CADSexism (medical judgment) – women are less likely to have and/or die from CAD Biological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” diseaseBiological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” disease

Paradox: Pathophysiological Gender Differences: FRISC II 749 women and 1,708 men with unstable coronary artery disease749 women and 1,708 men with unstable coronary artery disease Entry criteria = symptoms plus ischemia, defined as ECG change or + enzymesEntry criteria = symptoms plus ischemia, defined as ECG change or + enzymes Randomized to early invasive versus noninvasive strategyRandomized to early invasive versus noninvasive strategy Women were older, had fewer prior MI, better LVEF and lower troponin T levelsWomen were older, had fewer prior MI, better LVEF and lower troponin T levels Lagerqvist et al, JACC 2001;38:41

Women are less likely to have obstructive CAD BUT equally/more likely to die EF  45% 12%*14% No CAD 25%*10% LM/3 VD/2 VD/2 prox LAD 32%*43% Noninvasive (Death/MI) 11%16% Invasive (Death/MI) 12%11%** WomenMen Lagerqvist et al, JACC 2001;38:41 *p<0.05 vs men; ** P = vs noninvasive FemaleMale

Potential Explanations for Disparities in CVD Treatment in Women Blame the victim – women do not seek healthcare for symptoms and/or delay seeking attentionBlame the victim – women do not seek healthcare for symptoms and/or delay seeking attention Ageism – women are older on average and older patients are less aggressively treatedAgeism – women are older on average and older patients are less aggressively treated Sexism (medical judgment) – women are less likely to have and/or die from CADSexism (medical judgment) – women are less likely to have and/or die from CAD Biological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” diseaseBiological sex differences in CVD – women more often present with “female-pattern” disease, which is not recognized compared to “male-pattern” disease

Bugiardini and Bairey Merz JAMA 2005;293: Paradox: Women have a two-fold increase in “normal” coronary arteries in the setting of ACS, nonSTE and STE AMI

Female-pattern Ischemic Heart Disease Microvascular Coronary Disease (MCD) Angina Abnormal SPECT No obstructive CAD Abnormal coronary flow reserve and elevated LVEDP Diffuse atherosclerosis by IVUS NCDR estimate 3 million women in the US – a larger problem than breast cancer. Circulation. 1999;99:1774

Female-pattern IHD is Associated with Increased Risk of Major Adverse CV Events: NHLBI WISE Study _ Pepine JACC 2010

Challenges for Women With IHD ● Delays in symptom recognition and treatment ● Misdiagnosis ● Lower use of angiography, revascularization, aspirin, beta blockers, statins, agiotensin-converting enzyme inhibitors (ACE-I)(4 Magic Pills)* ● Less counseling and risk factor control ● Fewer referrals to cardiac rehab; more “drop-outs” ● Lower adherence to proven guidelines (ACC/AHA, NCEP, JNC VII, etc) ↑ Mortality * Associated with a 90% reduction in recurrent major adverse cardiac events

The Yentl Syndrome is Alive and Well in 2011 Bairey Merz, EHJ 2011 → Men > women with with recognized angina/ACS

The Yentl Syndrome is Alive and Well in 2011 Bairey Merz, EHJ 2011 → Men > women with with recognized angina/ACS → Men > women go to coronary angiography

The Yentl Syndrome is Alive and Well in 2011 Bairey Merz, EHJ 2011 → Men > women with with recognized angina/ACS → Men > women go to coronary angiography → Men > women receive guidelines Rx

The Yentl Syndrome is Alive and Well in 2011 Bairey Merz, EHJ 2011 → Men > women with with recognized angina/ACS → Men > women go to coronary angiography → Men > women receive guidelines Rx → Women > men death

What is the Answer? What is the Problem?What is the Problem? Lack of patient response to symptoms?Lack of patient response to symptoms? Provider sexism (medical judgment)?Provider sexism (medical judgment)? Ageism?Ageism? Lack of knowledge and recognition of female- pattern ischemic heart disease resulting in failure to use guidelines therapy?Lack of knowledge and recognition of female- pattern ischemic heart disease resulting in failure to use guidelines therapy?

What is the Answer? What is the Problem?What is the Problem? Lack of patient response to symptoms?Lack of patient response to symptoms? Provide sexism (medical judgment)?Provide sexism (medical judgment)? Ageism?Ageism? Lack of knowledge and recognition of female- pattern ischemic heart disease resulting in failure to use guidelines therapyLack of knowledge and recognition of female- pattern ischemic heart disease resulting in failure to use guidelines therapy

How to Get Results Re-name it “Ischemic Heart Disease (IHD) rather than “Coronary Artery Disease (CAD)”Re-name it “Ischemic Heart Disease (IHD) rather than “Coronary Artery Disease (CAD)” Use a simplified approach to IHD management helps to increase adherence to guidelinesUse a simplified approach to IHD management helps to increase adherence to guidelines This can be achieved using an ABC format to present important pharmacologic therapies and lifestyle approachesThis can be achieved using an ABC format to present important pharmacologic therapies and lifestyle approaches

Know Your ABCs A Antiplatelets/anticoagulants*Antiplatelets/anticoagulants* Angtiotensin-converting enzyme (ACE) inhibitors/angiotensin-receptor blockers (ARBs)*Angtiotensin-converting enzyme (ACE) inhibitors/angiotensin-receptor blockers (ARBs)* AntianginalsAntianginals B Blood pressure controlBlood pressure control Beta-blocker*Beta-blocker* C Cholesterol management (statin)*Cholesterol management (statin)* Cigarette smoking cessationCigarette smoking cessation * 4 Magic Pills

What About Women (and Men) with Female-Pattern Ischemic Heart Disease? Remember, ACS/angina guidelines are not “cath” based – treat evidence of ischemia and angina, not the cathRemember, ACS/angina guidelines are not “cath” based – treat evidence of ischemia and angina, not the cath Abundant evidence exists documenting lifesaving risk reduction of the 4 magic pills (ASA, ACE, BB, statin)Abundant evidence exists documenting lifesaving risk reduction of the 4 magic pills (ASA, ACE, BB, statin) The power of the prescription pen to implement guidelines therapy preferentially saves women’s livesThe power of the prescription pen to implement guidelines therapy preferentially saves women’s lives

This slide set was adapted from the following ACC/AHA guidelines: Cardiovascular Disease Prevention in Women 2004, 2007, 2010 Management of Patients With ST-Elevation Myocardial Infarction Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction Preventing Heart Attack and Death in Patients with Atherosclerotic Cardiovascular Disease Management of Patients with Chronic Stable Angina Update for Coronary Artery Bypass Graft Surgery Evaluation and Management of Chronic Heart Failure in the Adult The full-text guidelines and executive summaries are also available on the ACC and AHA websites at and Clinical Practice Guidelines ACC=American College of Cardiology, AHA=American Heart Association

Impact of AHA Get With The Guidelines-CAD Program on Quality of Care GWTG-CAD: 123 US Hospitals n=27,825 Labresh, Fonarow et al. Circulation 2003;108:IV-722

Guideline Implementation and ACS and the Sex Survival Gap Novak et al Am J Medicine 2008;121:602.

Guideline Implementation and ACS and the Sex Survival Gap Following guideline implementation, mortality for women improves and the sex gap narrows (RED) Novak et al Am J Medicine 2008;121:602. +

Guideline Implementation and ACS and the Sex Survival Gap Following guideline implementation, mortality for women improves and the sex gap narrows (RED) Persistent sex gap (BLUE) suggests more work still needed to understand sex- specific pathophysiology to improve outcomes for women and men Novak et al Am J Medicine 2008;121:602. +

1615PC Bairey-Merz/Slide #39 Women’s Ischemia Syndrome Evaluation WISE WISE-ISCHEMIA: A Companion Trial to the NHLBI-sponsored ISCHEMIA Noel Bairey Merz MD Carl Pepine MD Harmony Reynolds MD Leslee Shaw PhD Eileen Handberg PhD Rhonda Cooper-DeHoff PharmD John Spertus MD David Maron MD Judy Hochman MD International Study of Comparative Health Effectiveness with Medical and Invasive Approaches ISCHEMIA

Enrolled patients n=8650 ISCHEMIA - type Patients sent to cath lab clinically (evidence of ischemia) Randomized in main trial n=8000 No obstructive CAD by ISCHEMIA CCTA n ~ No obstructive CAD by clinical invasive coronary angiography n= Obstructive CAD WISE – ISCHEMIA Randomized trial n=2600 LM no obstructive CAD (US/Canada) ISCHEMIA eligible consent no obstructive CAD excluded Figure 1. ISCHEMIA-WISE Companion Trial to ISCHEMIA

Atherothombotic Strategy Atorvastatin mg daily Aspirin mg daily Hypertension / Angina Strategy Step 1 Metoprolol mg or Verapamil SR mg if metoprolol intolerant daily Step 2 Add ramipril mg daily or losartan mg daily for ramipril intolerant Step 3 Add HCTZ mg daily Continued Angina Strategy Step 1 Isosorbide mononitrate mg daily Step 2 Add ranolazine mg twice daily

Current Strategies Not Working Optimally in Women 0 Problem: Adverse Mortality Gap Resulting in a New Female CVD Majority (National Center for Health Statistics and American Heart Association) NHLBI WISE Study And Guidelines Campaigns

Cardiovascular disease mortality trends for males and females United States: ). Cardiovascular disease mortality trends for males and females (United States: ). Source: NCHS and NHLBI 0 Problem: Adverse Mortality Gap Resulting in a New Female CVD Majority Solution: Clinical Translational Research and Guidelines NHLBI WISE Study, NHLBI and AHA Red Dress Awareness and Guidelines Campaigns

Summary: Women and Heart Disease Women face a higher mortality from IHD due to their relatively higher prevalence of “female-pattern” ischemic heart diseaseWomen face a higher mortality from IHD due to their relatively higher prevalence of “female-pattern” ischemic heart disease Application of guidelines therapy is improving outcomes in women with IHD. Ongoing work is evaluating mechanisms and interventions directed at sex differences in IHD. Questions, comments, referrals? comments, referrals?